| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:759.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
From the Cardiovascular Institute (F.S.V., M.C., D.F., J.D.M., B.J.K., J.S.L.), University of Pittsburgh School of Medicine, Pittsburgh, Pa, and Scios Inc (J.A.A., G.F.S., U.S.), Sunnyvale, Calif.
Correspondence to Flordeliza S. Villanueva, MD, University of Pittsburgh, S568 Scaife Hall, Pittsburgh, PA 15213. E-mail villanuevafs{at}msx.upmc.edu
Background Therapeutic angiogenesis is a new approach to treating ischemic heart disease, and the optimal method for assessing its efficacy is unclear. We used myocardial contrast echocardiography (MCE) to evaluate the therapeutic response to the angiogenic agent, vascular endothelial growth factor-121 (VEGF121).
Methods and Results After placement of an ameroid constrictor (day 0) around the left anterior descending artery (LAD), dogs were given intracoronary VEGF121 protein (108 µg, n=6) or placebo (n=6) on days 7 and 21, and subcutaneous VEGF121 (1 mg) or placebo on days 8 to 20 and 22 to 27. On day 48, MCE was performed during rest and dobutamine stress. Videointensity (y) and pulsing interval (t) were fit to an exponential model (y=A[1-e-ßt]) used to derive indices of red cell velocity (ß) and capillary area (A), and parameters were compared with radiolabeled microsphere flow data. VEGF121 treatment resulted in higher resting left anterior descending artery/left circumflex flow ratio compared with placebo (P<0.03) and improved collateral flow reserve. ß was 0.94±0.37 in VEGF121 dogs versus 0.38±0.31 in controls (P<0.02), with the greatest difference in the endocardium. The parameter A was comparable in both groups, suggesting that microvascular changes did not alter capillary cross-sectional area, and histology indicated a trend toward higher arteriolar density in VEGF121-treated animals.
Conclusions VEGF121 protein improves collateral flow and reserve. MCE can evaluate the transmural location and structural and functional responses of the microvasculature to angiogenic interventions.
Key Words: echocardiography angiogenesis coronary disease
This article has been cited by other articles:
![]() |
J. J. Pacella and F. S. Villanueva Effect of Coronary Stenosis on Adjacent Bed Flow Reserve: Assessment of Microvascular Mechanisms Using Myocardial Contrast Echocardiography Circulation, October 31, 2006; 114(18): 1940 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Pacella, M. V. Kameneva, M. Csikari, E. Lu, and F. S. Villanueva A novel hydrodynamic approach to the treatment of coronary artery disease Eur. Heart J., October 1, 2006; 27(19): 2362 - 2369. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Paltiel, L. A. Kalish, R. A. Susaeta, F. Frauscher, P. L. O'Kane, and L. G. Freitas-Filho Pulse-Inversion US Imaging of Testicular Ischemia: Quantitative and Qualitative Analyses in a Rabbit Model Radiology, June 1, 2006; 239(3): 718 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lucidarme, S. Franchi-Abella, J.-M. Correas, S. L. Bridal, E. Kurtisovski, and G. Berger Blood Flow Quantification with Contrast-enhanced US: "Entrance in the Section" Phenomenon--Phantom and Rabbit Study Radiology, August 1, 2003; 228(2): 473 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lu, W. R. Wagner, U. Schellenberger, J. A. Abraham, A. L. Klibanov, S. R. Woulfe, M. M. Csikari, D. Fischer, G. F. Schreiner, G. H. Brandenburger, et al. Targeted In Vivo Labeling of Receptors for Vascular Endothelial Growth Factor: Approach to Identification of Ischemic Tissue Circulation, July 8, 2003; 108(1): 97 - 103. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |